Selective lateral spinal cord stimulation
By identifying and targeting lateral spinal cord nerve targets such as the dorsal root, dorsal branch root, or dorsal root entry area, and using epidural sutures for lateral placement, the problem of inaccurate localization of lateral spinal cord stimulation in existing technologies is solved, achieving a more efficient pain treatment effect.
Patent Information
- Application Number
- CN202280012904.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2021-02-01
- Filing Date
- 2022-01-31
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2042-01-31
AI Technical Summary
Existing spinal cord lateral stimulation techniques have difficulty accurately locating nerve targets when treating focal pain, resulting in high surgical complexity and the potential for adverse stimulation spillover or failure to effectively cover the pain area.
By identifying and targeting lateral spinal nerve targets such as the dorsal root, dorsal branch root, or dorsal root entry area, and using epidural leads for lateral placement, stimulation of the DRG, ventral root, or spinal nerve roots is avoided, providing a more effective electrical stimulation pattern for treating focal pain.
It simplifies surgical procedures, improves the accuracy of pain coverage, reduces the spillover of adverse stimuli, and provides more effective pain relief.
Smart Images

Figure CN116887885B_ABST
Abstract
Description
[0001] Priority requirements
[0002] This application claims the benefit of priority to U.S. Provisional Patent Application No. 63 / 144,387, filed February 1, 2021, the entire contents of which are incorporated herein by reference. Technical Field
[0003] This document generally relates to medical devices, and more particularly to systems, devices, and methods for delivering neural modulation. Background Technology
[0004] Neuromodulation (or “neural neuromodulation,” also known as “neurostimulation” or “neural stimulation”) has been proposed as a therapy for a variety of conditions. Generally, neuromodulation and neurostimulation are used interchangeably to describe excitatory stimuli that elicit action potentials, as well as inhibitory and other effects. Examples of neuromodulation include spinal cord stimulation (SCS), deep brain stimulation (DBS), peripheral nerve stimulation (PNS), and functional electrical stimulation (FES). By way of example, and not limitation, SCS has been used to treat chronic pain syndromes.
[0005] Some neural targets can be complex structures with different types of nerve fibers. An example of such a complex structure is the intraspinal and peripheral neuronal units targeted by SCS. This complexity can lead to difficulties in placing modulation electrodes in different patients and programming one or more modulation fields, as the optimal placement of the modulation electrode and the optimal modulation field for treating a specific pain area may differ between patients. Although physicians may guide the lead using only the skeletal anatomy detected by fluoroscopy, they cannot accurately determine the underlying neural structures (neuroanatomy) of a particular patient from fluoroscopic images.
[0006] Lateral simulation of the nerve fibers innervating the spinal cord can be used to target focal pain, such as pain in the foot, knee, or hip. This lateral simulation can be provided using a technique employing an epidural mid-line lead targeting the dorsal column. Implantation of a midline epidural lead is a relatively straightforward surgical procedure that does not require specialized surgical training. However, a midline epidural lead may or may not provide the desired coverage of the focal pain area, and may or may not provide stimulation spillover. Furthermore, finding a setting that covers both lower back pain and focal pain can be challenging. In another technique, an epidural lead can be placed to target the dorsal root ganglion (DRG). This method provides good focal pain coverage. However, the procedure is more complex (e.g., complex manipulation), which may require specialized training for the physician. Additionally, using a small treatment window to stimulate the DRG may lead to overstimulation. Another technique uses peripheral nerve stimulation, which can provide good focal pain coverage. However, the surgical procedure is more complex in order to access the target peripheral nerve and ensure proper placement of the suture. Peripheral nerve stimulation may also more likely stimulate both motor and sensory axons.
[0007] Therefore, other, more effective spinal cord lateral stimulation protocols are needed to treat focal pain. Summary of the Invention
[0008] The various embodiments discussed in this document can target lateral spinal cord nerve targets (such as the dorsal root, dorsal rootlet, or dorsal root entry zone, DREZ) instead of other nerve targets (such as the DRG, ventral root, etc.). The system provides more effective lateral spinal cord stimulation by targeting the dorsal root (or spinal nerve root). Systems and methods are provided to instruct users (e.g., physicians) to program leads placed epidurally, within the intervertebral foramen, or through the sacral hiatus. Various embodiments can identify lateral spinal cord nerve targets corresponding to epidural lead placement and focal pain areas, and automatically populate a set of optional treatment options (e.g., electrode configurations for nerve stimulation). By selectively or preferentially targeting sensory fibers in the dorsal root, dorsal branch root, or DREZ to treat focal pain, the system can avoid the adverse effects of stimulating the DRG, ventral root, or spinal nerve roots. Lateral placement of leads targeting these lateral nerve targets via the epidural space (hereinafter referred to as "epidural leads") can also simplify surgical procedures. For example, lateral placement of epidural leads discussed in this document does not require placing the lead outside the intervertebral foramen, as long as the most distal lead contact is within the intervertebral foramen region. The lead also does not need to be placed below the conus medullaris, as its target is the root terminal at the spinal cord inlet.
[0009] The following examples illustrate various aspects of the embodiments described herein.
[0010] Example 1 is a system for providing spinal cord electrical stimulation for pain control in a patient. The system includes: a programming device configured to: receive information regarding the placement of at least one lead near a lateral portion of the spinal cord; identify one or more lateral spinal cord targets based on the information regarding the placement of the at least one lead; and receive a user selection from an optional stimulation pattern for stimulating the identified one or more lateral spinal cord targets; and an electrical stimulator configured to apply electrical stimulation energy via the at least one lead to the identified one or more lateral spinal cord targets according to the user selection from the optional stimulation pattern.
[0011] In Example 2, the subject of Example 1 may optionally include one or more lateral spinal cord targets, which may include at least one of the dorsal root entry area, dorsolateral tract, dorsal root, or dorsal branch root.
[0012] In Example 3, any one or more of the themes in Examples 1-2 may optionally include optional stimulation modes, which may include at least one of the following: monopolar stimulation mode; bipolar stimulation mode; tripolar stimulation mode; turning mode; sensory mode; rotation mode; rapid-acting subsensory therapy mode; dorsal horn modulation mode; burst mode; or low-rate active recharge mode.
[0013] In Example 4, any one or more of the subjects in Examples 1-3 may optionally include the placement of at least one lead, which may include a user selection from two or more of cylindrical leads, paddle leads, directional leads, or curved leads, wherein the curved lead includes two or more cascaded lead segments arranged at an angle relative to each other.
[0014] In Example 5, any one or more of the subjects in Examples 1-4 may optionally include a programming device that can be configured to identify one or more lateral spinal cord targets, including: generating one or more contact sets, each contact set including a lead electrode-tissue contact on a lateral portion of the patient's spinal cord; and identifying one or more lateral spinal cord targets for each of the one or more contact sets.
[0015] In Example 6, the subject of Example 5 may optionally include one or more lateral spinal nerve targets, which may include at least one of the following: a first lateral spinal nerve target identified for a first contact group, including a dorsal column, dorsal ramus root, dorsal root entry area, dorsolateral tract, and inhibitory interneuron; a second lateral spinal nerve target identified for a second contact group, including one or more midline dorsal roots; or a third lateral spinal nerve target identified for a third contact group, including one or more lateral dorsal roots.
[0016] In Example 7, any one or more of the subjects in Examples 5-6 may optionally include a programming device that can be configured to: receive information about a painful area on a patient's body, the painful area corresponding to one or more dermatomes; and further identify one or more lateral spinal nerve targets of the contact group based on the rostral-caudal position or medio-lateral position of the contact group relative to the spinal cord level innervating the one or more dermatomes corresponding to the painful area.
[0017] In Example 8, any one or more of the subjects in Examples 5-7 may optionally include optional stimulation patterns. For each of the one or more contact groups, the optional stimulation patterns may include one or more candidate stimulation patterns based on sensory abnormalities and one or more candidate stimulation patterns without sensory abnormalities.
[0018] In Example 9, any one or more of the subjects in Examples 5-8 may optionally include a programming device that can be configured to: receive a user selection from candidate spinal nerve targets for each of one or more groups of contacts; and provide an optional stimulation pattern for the user-selected candidate spinal nerve target.
[0019] In Example 10, the subject of Example 9 may optionally include candidate spinal cord nerve targets, which may include one or more of the following: dorsal column; dorsal horn; dorsolateral tract; dorsal root entry area; dorsal branch root; or dorsal root.
[0020] In Example 11, any one or more of the topics in Examples 9-10 may optionally include optional stimulation patterns, which for each candidate spinal cord target may include one or more candidate stimulation patterns based on sensory abnormalities and one or more candidate stimulation patterns without sensory abnormalities.
[0021] In Example 12, any one or more of the subjects in Examples 1-11 may optionally include: an electrical stimulator configured to apply test electrical stimulation energy individually and independently to two or more identified lateral spinal nerve targets according to corresponding stimulation patterns selected for each of the two or more identified lateral spinal nerve targets; and a programming device configured to select one of the two or more identified lateral spinal nerve targets based on patient feedback of pain relief, the pain relief being in response to electrical stimulation applied individually and independently to the two or more identified lateral spinal nerve targets; wherein the electrical stimulator is configured to apply clinical electrical stimulation energy to the selected nerve target according to the corresponding stimulation pattern.
[0022] In Example 13, the subject of Example 12 optionally includes a display configured to display two or more identified lateral spinal nerve targets and stimulation patterns selected for each of the two or more identified lateral spinal nerve targets, wherein the programming device is configured to receive a user selection for one of the two or more identified lateral spinal nerve targets based on patient feedback of pain relief in response to electrical stimulation applied individually and independently to each of the two or more identified lateral spinal nerve targets.
[0023] In Example 14, any one or more of the subjects in Examples 1-13 may optionally include a programming device that can be configured to receive a user selection from optional stimulation patterns, which include two or more stimulation patterns that will be applied to corresponding two or more sets of electrodes to stimulate corresponding two or more lateral spinal cord targets.
[0024] In Example 15, the subject matter of Example 14 may optionally include user selection of two or more stimulation modes, which may include a monopolar anodic stimulation mode applied to a first electrode set to stimulate the dorsal root entry area at a spinal cord segment, and a bipolar stimulation mode applied to a second electrode set to stimulate the dorsal column or dorsal root at a spinal cord segment.
[0025] Example 16 is a non-transitory machine-readable storage medium including instructions that, when executed by one or more processors of the machine, cause the machine to perform operations including: receiving information regarding the placement of at least one lead near a lateral portion of a patient's spinal cord; identifying one or more lateral spinal cord targets based on the information regarding the placement of the at least one lead; receiving a user selection from an optional stimulation pattern for stimulating the identified one or more lateral spinal cord targets; and applying electrical stimulation energy to the identified one or more lateral spinal cord targets via the at least one lead, according to the user selection from the optional stimulation pattern.
[0026] In Example 17, the subject matter of Example 16 may optionally include, wherein one or more lateral spinal cord targets include at least one of the dorsal root entry area, dorsolateral tract, dorsal root, or dorsal branch root.
[0027] In Example 18, the subject matter of any one or more of Examples 16-17 may optionally include, wherein the operation of identifying one or more lateral spinal cord targets includes: generating one or more contact groups, each contact group including a lead electrode-tissue contact on a lateral portion of the patient's spinal cord; and identifying one or more lateral spinal cord targets for each of the one or more contact groups.
[0028] In Example 19, the subject matter of Example 18 may optionally include an instruction that causes the machine to perform operations including receiving information about a painful area on the patient's body, the painful area corresponding to one or more dermatomes, and wherein the operation of identifying one or more lateral spinal nerve targets of a group of contacts is also based on the cephalo-caudal or intermediate-lateral position of the group of contacts relative to the spinal cord segment innervating the one or more dermatomes corresponding to the painful area.
[0029] In Example 20, any one or more of the topics in Examples 16-19 may optionally be included, wherein the optional stimulus patterns include one or more candidate stimulus patterns based on sensory abnormalities and one or more candidate stimulus patterns without sensory abnormalities.
[0030] In Example 21, the subject matter of any one or more of Examples 16-20 may optionally include, wherein the instruction causes the machine to perform operations further comprising: applying test electrical stimulation energy individually and independently to two or more identified lateral spinal nerve targets according to corresponding stimulation patterns selected for each of the two or more identified lateral spinal nerve targets; selecting one of the two or more identified lateral spinal nerve targets based on patient feedback of pain relief, the pain relief being in response to electrical stimulation applied individually and independently to the two or more identified lateral spinal nerve targets; and applying clinical electrical stimulation energy to the selected nerve target according to the corresponding stimulation pattern.
[0031] Example 22 is a method for providing spinal cord electrical stimulation to a patient to control pain. The method includes the steps of: receiving information about the placement of at least one lead near a lateral portion of the spinal cord; identifying one or more lateral spinal nerve targets using a programming device based on the information about the placement of the at least one lead; receiving a user selection from an optional stimulation pattern for stimulating the identified one or more lateral spinal nerve targets; and applying electrical stimulation energy generated by an electrical exciter via the at least one lead to the identified one or more lateral spinal nerve targets, according to the user selection from the optional stimulation pattern.
[0032] In Example 23, the subject matter of Example 22 may optionally include identifying one or more lateral spinal cord targets, which may include: generating one or more contact sets, each contact set including a lead electrode-tissue contact on a lateral portion of the patient's spinal cord; and for each of the one or more contact sets, identifying one or more lateral spinal cord targets, which include at least one of the following: a first lateral spinal cord target identified for a first contact set, including a dorsal column, dorsal ramus root, dorsal root entry area, dorsolateral tract, and inhibitory interneuron; a second lateral spinal cord target identified for a second contact set, including one or more midline dorsal roots; or a third lateral spinal cord target identified for a third contact set, including one or more lateral dorsal roots.
[0033] In Example 24, the subject matter of Example 23 may optionally include receiving information about a painful area on a patient's body that corresponds to one or more dermatomes, wherein identifying one or more lateral spinal nerve targets of a group of contacts is also based on the cephalo-caudal or intermediate-lateral position of the group of contacts relative to the spinal segment innervating the one or more dermatomes corresponding to the painful area.
[0034] This summary is an overview of some of the teachings of this application and is not intended to be exclusive or exhaustive of the subject matter. Further details regarding the subject matter are found in the detailed description and the appended claims. Other aspects of this disclosure will become apparent to those skilled in the art upon reading and understanding the following detailed description and examining the accompanying drawings, which form a part of it, and each drawing should not be considered limiting. The scope of this disclosure is defined by the appended claims and their legal equivalents. Attached Figure Description
[0035] Various embodiments are illustrated by way of example in the accompanying drawings. Such embodiments are illustrative and are not intended to be exhaustive or exclusive embodiments of the subject matter.
[0036] Figure 1A-1B A portion of the spinal cord is shown.
[0037] Figure 2 An example embodiment of the neural modulation system is shown.
[0038] Figure 3 Examples are shown such as that can be Figure 2 An example of a modulation device implemented in a neural modulation system.
[0039] Figure 4 Examples are shown such as those that can be implemented as Figure 2 An example of a programming device in a neural modulation system.
[0040] Figure 5 An implantable neural modulation system and a partial environment in which the system can be used are illustrated as examples.
[0041] Figure 6 An example of a spinal cord stimulation (SCS) system, which may also be referred to as a spinal cord modulation (SCM) system, is shown by way of example.
[0042] Figure 7 Some features of the neural modulation leads and waveform generator are illustrated by way of example.
[0043] Figure 8 Partial views of the neuroanatomical and bony structures of the spine are shown.
[0044] Figures 9A-9C The transverse top view, coronal lateral view, and angled view of the nerve root are shown respectively.
[0045] Figure 10A-10G Various examples of placing leads on the spinal cord are shown as examples.
[0046] Figure 10H The breakdown of the anodic current delivered to the electrode on the electroneural modulation lead is illustrated by way of example.
[0047] Figure 11A-11B Epidural lead placement is illustrated as an example.
[0048] Figure 12A and Figure 12B The anatomical areas (pain sites) on the patient's body that feel pain are shown as examples.
[0049] Figure 13 This diagram roughly illustrates an example of dermatomes in the human body and their corresponding spinal nerves originating from the spinal cord.
[0050] Figure 14 A block diagram of a neural modulation system is shown as an example, which provides an optional lateral SCS for pain control.
[0051] Figure 15A-15F The user interface for programming the optional lateral SCS for pain control is shown as an example.
[0052] Figures 16A-16D The user interface for programming the optional lateral SCS for pain control is shown as an example.
[0053] Figures 17A-17B The user interface for programming the SCS to target multiple central stimulation points (CPS) using electrodes on different sections of the epidural lead is shown as an example.
[0054] Figure 18 This is a flowchart illustrating, by way of example, a method for programming and applying optional lateral SCS for pain control.
[0055] Figure 19 A block diagram of the example machine 1900 is shown in general, and any one or more of the techniques (e.g., methods) discussed herein can be executed on the example machine 1900. Detailed Implementation
[0056] The following detailed description of the subject matter is illustrated with reference to the accompanying drawings, which show specific aspects and embodiments in which the subject matter can be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the subject matter. Other embodiments may be utilized, and structural, logical, and electrical changes may be made without departing from the scope of the subject matter. References to “an,” “one,” or “various” embodiments in this disclosure do not necessarily refer to the same embodiment, and such references contemplate more than one embodiment. Therefore, the following detailed description should not be considered limiting, and its scope is defined only by the appended claims and the full scope of their legal equivalents.
[0057] The various embodiments described herein relate to spinal cord regulation. A brief description of spinal cord physiology is provided to assist the reader. Figure 1A-1B A portion of the spinal cord 100, comprising white matter 101 and gray matter 102, is illustrated by way of example. Gray matter 102 includes cell bodies, synapses, dendrites, and axonal terminals. Thus, synapses are located within the gray matter. White matter 101 comprises myelinated axons connecting regions of gray matter. A typical cross-section of the spinal cord includes a central “butterfly” shaped region of gray matter 102, which is substantially surrounded by an elliptical outer region of white matter 101. The white matter of the dorsal column (DC) 103 primarily comprises large myelinated axons forming axially extending afferent fibers. The dorsal portion of the central region of the “butterfly” shaped gray matter is called the dorsal horns (DH) 104. Unlike the axially extending DC fibers, DH fibers can be oriented in many directions, including perpendicular to the longitudinal axis of the spinal cord. Figure 1A-1B The spinal nerves are also shown, including the dorsal root (DR) 105, dorsal branch root 109, dorsal root ganglion (DRG) 106, ventral root 107, and ventral branch root 117. The dorsal root 105 primarily carries sensory signals into the spinal cord via the dorsal root entry zone (DREZ) 119 of DH 104, while the ventral root 107 acts as an efferent motor root, primarily carrying motor signals out of the spinal cord. The dorsal and ventral roots join to form a mixed spinal nerve root 108.
[0058] SCS has been used for pain relief. The therapeutic goal of conventional SCS programming is to maximize stimulation (i.e., recruitment) of DC fibers extending along the spinal cord longitudinal axis in the white matter and minimize stimulation of other fibers extending perpendicular to the spinal cord longitudinal axis (primarily dorsal root fibers), as shown in Figure 1. The white matter of the DCs primarily consists of large myelinated axons that form afferent fibers. While the full mechanisms of pain relief are not well understood, it is believed that the perception of pain signals is inhibited via a pain-gated theory, which suggests that enhanced activity of harmless touch or pressure afferents via electrical stimulation generates interneuronal activity within the DH of the spinal cord, which releases inhibitory neurotransmitters (γ-aminobutyric acid (GABA), glycine), which in turn reduces the hypersensitivity of wide dynamic range (WDR) sensory neurons to harmful afferent inputs of pain signals from dorsal root (DR) nerve fibers innervating the patient's pain area, and treats general WDR heterotopia. Therefore, the large sensory afferents of the DC nerve fibers are directed to stimulate to provide pain relief. Currently implantable neuromodulation systems typically include electrodes located adjacent to the patient's spinal dorsal column, i.e., on or near the dura mater, and electrodes implanted along the longitudinal axis of the patient's spinal cord.
[0059] This topic provides systems and methods for selectively or preferentially stimulating DR tissues rather than other neural tissues, such as, but not limited to, the dorsal root, dorsal branch root, DRG, DREZ, or dorsolateral bundle. One or more leads, including multiple electrodes, can be positioned to place multiple electrodes near the target nerve root. For example, electrodes can be placed near the target nerve root, dorsal root, or DREZ. One or more leads can be placed using surgical approaches, such as a lateral antegrade approach, a lateral retrograde approach, a sacral hiatus approach, or a crossover approach. The lateral antegrade approach inserts the lead into the epidural space below the target location and then advances it in an antegrade direction (towards the head) until the lead is at the target nerve root. The lateral retrograde approach can be used for selective root stimulation by inserting the lead above the epidural target and then advancing it in a retrograde direction (away from the head) towards the target nerve root, bringing the lead closer to the DRG. The sacral hiatus approach introduces a guide needle through the sacral hiatus into the epidural space and advances it in an antegrade direction (towards the head) to the target nerve root. After reaching the target nerve, a guide wire can be passed through the intervertebral foramen to locate electrodes outside, inside, and within the spinal canal along the target nerve root. An antegrade approach is then used to enter the contralateral interstitial space, and the guide wire is led out of the opposite intervertebral foramen to locate electrodes outside, inside, and within the spinal canal along the target nerve root.
[0060] Stimulation of the DR tissue can be used to treat focal pain because it provides the necessary coverage of the pain without spilling over stimulation that could cause undesirable effects in other areas of the body. Stimulation of the DR tissue can also be used to deliver subsensory therapy, avoiding the sensory abnormalities associated with conventional SCS therapy when large sensory DC nerve fibers are activated. Patients sometimes report these sensations as unwanted. Subsensory therapy can effectively treat pain without the patient perceiving the delivery of the modulated field (e.g., sensory abnormalities). Selective modulation of the DR tissue, whether used for subsensory therapy or for treating focal pain, can be delivered at higher frequencies (e.g., above 1500 Hz, such as frequencies in the 2 kHz to 20 kHz range) or at lower frequencies (e.g., at or below 1500 Hz, such as at or below 1200 Hz, at or below 1000 Hz, at or below 500 Hz, at or below 350 Hz, or at or below 130 Hz). Selective modulation can be delivered at low frequencies (e.g., as low as 2 Hz), or even without a pulse (e.g., 0 Hz). By way of example, and not limitation, selective modulation can be delivered within a frequency range selected from the following frequency ranges: 2 Hz to 1200 Hz; 2 Hz to 1000 Hz; 2 Hz to 500 Hz; 2 Hz to 350 Hz; or 2 Hz to 130 Hz. Systems can be developed to increase the lower end of any of these ranges from 2 Hz to other frequencies, such as, but not limited to, 10 Hz, 20 Hz, 50 Hz, or 100 Hz. By way of example, and not limitation, it is also noted that selective modulation can be delivered in terms of duty cycle, wherein a stimulus (e.g., a pulse train) is delivered during the stimulus-on portion of the duty cycle and not delivered during the stimulus-off portion. By way of example, and not limitation, the duty cycle can be approximately 10% ± 5%, 20% ± 5%, 30% ± 5%, 40% ± 5%, 50% ± 5%, or 60% ± 5%. For example, a pulse train lasting 10 ms during the stimulus-on portion, followed by 15 ms without pulses, corresponds to a 40% duty cycle. Some waveforms can combine lower-frequency pulses and higher-frequency pulses into more complex waveforms (e.g., higher-frequency pulse trains interleaved between one or more pulses delivered at lower frequencies). The waveform can have a regular pulse pattern, repeating at regular intervals between pulses or between pulse trains. The waveform can also have an irregular pulse pattern, including varying intervals between pulses and / or varying gaps between pulse trains. The waveform can include straight pulses, or it can include other non-linear shapes.
[0061] Figure 2An embodiment of a neural modulation system is illustrated. The illustrated system 210 includes electrodes 211, a modulation device 212, and a programming device 213. Electrodes 211 are configured to be placed on or near one or more neural targets in a patient, such as one or more dorsal nerve roots. The modulation device 212 is configured to be electrically connected to the electrodes 211 and to deliver neurally modulated energy (such as in the form of electrical pulses or other waveforms) to the one or more neural targets through the electrodes 211. The modulation device 212 may be an implantable or external device having percutaneously inserted leads for positioning to stimulate the dorsal roots. The delivery of neural modulation is controlled by using multiple modulation parameters, such as specifying modulation parameters for electrical pulses and selecting one or more electrodes to serve as one or more anodes and one or more electrodes to serve as one or more cathodes through which each electrical pulse is delivered. The modulation parameters may also include a fractional distribution of energy (e.g., current) provided between one or more anode electrodes and one or more cathode electrodes. In various embodiments, at least some of the multiple modulation parameters may be programmed by a user (such as a physician or other caregiver). The programming device 213 provides the user with access to user-programmable parameters. In various embodiments, the programming device 213 is configured to be communicatively coupled to the modulation device via a wired or wireless link. In various embodiments, the programming device 213 includes a graphical user interface (GUI) 214 that allows a user to set and / or adjust values of user-programmable modulation parameters.
[0062] Figure 3 An embodiment of the neural modulation device 312 is shown, such as one that can be used in... Figure 2The neural modulation system 210 is implemented. An embodiment of the shown neural modulation device 312 includes a neural modulation output circuit 315 and a neural modulation control circuit 316. Those skilled in the art will understand that the neural modulation device 312 may include additional components such as sensing circuitry, telemetry circuitry, and a power supply for patient monitoring and / or treatment feedback control. The neural modulation output circuit 315 generates and delivers neural modulation pulses. The neural modulation control circuit 316 controls the delivery of neural modulation pulses using multiple neural modulation parameters. The combination of the neural modulation output circuit 315 and the neural modulation control circuit 316 can be collectively referred to as a pulse generator. The lead system 317 includes one or more leads, each configured to be electrically connected to the neural modulation device 312, and multiple electrodes 311-1 to 311-N (where N ≥ 2) distributed in an electrode arrangement using one or more leads. Each lead may have an electrode array consisting of two or more electrodes, which may also be referred to as contacts. Multiple leads can provide multiple electrode arrays to provide an electrode arrangement. Each electrode is a single conductive contact that provides an electrical interface between the neural modulation output circuit 315 and the patient tissue. Neural modulation pulses are delivered from the neural modulation output circuit 315 via a set of electrodes selected from electrodes 311-1 to 311-N. The number of leads and the number of electrodes on each lead can depend on, for example, the distribution of one or more targets of neural modulation and the need to control the electric field distribution at each target. In one embodiment, by way of example and not limitation, the lead system includes two leads, each with eight electrodes. Some embodiments may use lead systems comprising one or more leads of the same or different types, such as percutaneous leads, linear paddles, multi-row paddles, or directional leads.
[0063] Neuromodulation systems can be configured to modulate target tissue in the spinal cord or other neural tissue. Electrode configurations used to deliver electrical pulses to the target tissue constitute an electrode configuration, wherein the electrodes can be selectively programmed to act as anodes (positive), cathodes (negative), or off (zero). In other words, the electrode configuration represents polarity as positive, negative, or zero. One or more electrode configurations can be used to control or modify the electrical waveform used for delivery. The electrical waveform can be an analog signal or a digital signal. In some embodiments, the electrical waveform includes pulses. Pulses can be delivered in a regular, repetitive pattern, or they can be delivered using complex, seemingly irregular pulse patterns. Other parameters that can be controlled or modified include the amplitude, pulse width, and rate (or frequency) of the electrical pulses. Each electrode configuration and the electrical pulse parameters can be referred to as a "neuromodulation parameter set." Each set of neuromodulation parameters, including the subdivided current distribution of the electrodes (cathode current percentage, anode current percentage, or off), can be stored and combined into a neuromodulation program, which can then be used to modulate multiple regions within the patient's body.
[0064] The combination of the number of available electrodes and the ability to generate a wide variety of complex electrical pulses presents clinicians or patients with a vast selection of neural modulation parameter sets. For example, if a neural modulation system to be programmed has sixteen electrodes, millions of neural modulation parameter sets can be used to program the system. Furthermore, an SCS system, for example, can have 32 electrodes (plus additional electrodes in the "canister" or device housing), which multiplies the number of neural modulation parameter sets available for programming. To facilitate this selection, clinicians typically program the neural modulation parameter sets via a computer programming system, allowing the optimal neural modulation parameters to be determined based on patient feedback or other means, and then programming the desired set of neural modulation parameters.
[0065] Patient-perceived sensory abnormalities can be used to program SCS (Self-Controlled Cognitive Surgery) treatment, such as by selecting or determining an appropriate set of neural modulation parameters. Sensory abnormalities induced by neural modulation and perceived by the patient may be located in roughly the same location on the patient's body where pain is felt, and are therefore also target sites for treatment. Traditionally, when leads are implanted in the patient, an operating room (OR) mapping procedure can be performed to apply neural modulation to test the placement of the leads and / or electrodes, thereby ensuring that the leads and / or electrodes are implanted in the effective location within the patient's body.
[0066] Once the lead is correctly positioned, an assembly procedure, which may be called a navigation procedure, can be executed to program the external control device and the neuromodulation device (if applicable) using a set of neuromodulation parameters that best address the pain site. Thus, the navigation session can be used to precisely locate the volume of activation (VOA) or the area associated with pain. This procedure can be implemented to target the tissue if the lead gradually or accidentally moves away from the target site during or after implantation, potentially repositioning the neuromodulation energy. By reprogramming the neuromodulation device (typically by independently changing the neuromodulation energy on the electrodes), the VOA can often be moved back to the effective pain site without requiring reoperation with the patient to reposition the lead and its electrode array. According to the various embodiments discussed in this document, in addition to information about dermal coverage (such as the correspondence between the painful body part and the body part inducing paresthesia), one or more patient-related information (such as feedback on inducing paresthesia or the patient's perceptual threshold) can be used to optimize the target neuromodulation field. This not only improves neuromodulation accuracy, resulting in better therapeutic outcomes, but also saves system operator time and reduces the burden of programming the neuromodulation system.
[0067] Figure 4 An embodiment of the programming device 413 is shown, such as that which can be used as... Figure 2The programming device 413 is implemented in a neural modulation system. The programming device 413 includes a storage device 419, a programming control circuit 420, and a GUI 414. The programming control circuit 420 generates multiple modulation parameters that control the delivery of neural modulation pulses according to the pattern of the neural modulation pulses. In various embodiments, the GUI 414 includes any type of presentation device, such as an interactive or non-interactive screen, and any type of user input device that allows the user to program the modulation parameters, such as a touchscreen, keyboard, keypad, touchpad, trackball, joystick, and mouse. The storage device 419 may store modulation parameters to be programmed into the modulation device. The modulation parameters may be organized into one or more sets of modulation parameters. The programming device 413 may send multiple modulation parameters to the modulation device. In some embodiments, the programming device 413 may send power to the modulation device. The programming control circuit 420 may generate multiple modulation parameters. In various embodiments, the programming control circuit 420 may check the values of the multiple modulation parameters against safety rules to limit these values within the constraints of the safety rules.
[0068] In various embodiments, neural modulation circuitry can be implemented using a combination of hardware, software, and firmware, including the various embodiments discussed herein. For example, GUI circuitry, modulation control circuitry, and programming control circuitry, including the various embodiments discussed herein, can be implemented using dedicated circuitry configured to perform one or more specific functions or general-purpose circuitry programmed to perform one or more such functions. Such general-purpose circuitry includes, but is not limited to, a microprocessor or a portion thereof, a microcontroller or a portion thereof, and programmable logic circuitry or a portion thereof.
[0069] Figure 5An implantable neural modulation system and a partial environment in which the system can be used are illustrated by way of example. The system is shown for implantation near the spinal cord. System 521 includes an implantable system 522, an external system 523, and a telemetry link 524 that provides wireless communication between the implantable system 522 and the external system 523. The implantable system is shown for implantation in a patient. The implantable system 522 includes an implantable modulation device (also referred to as an implantable pulse generator or IPG) 512, a lead system 518, and electrodes 511. The lead system 518 includes one or more leads and a plurality of electrodes 511 distributed among the one or more leads, each lead being configured to be electrically connected to the modulation device 512. In various embodiments, the external system 523 includes one or more external (non-implantable) devices, each device allowing a user (e.g., a clinician or other caregiver and / or patient) to communicate with the implantable system 522. In some embodiments, the external system 523 includes a programming device for a clinician or other caregiver to initialize and adjust settings of the implantable system 522 and a remote control device for use by a patient. For example, a remote control device may allow the patient to turn treatment on and off and / or adjust certain patient-programmable parameters among multiple modulation parameters. External system 523 may include other local or remote server or computer systems accessible via various networks.
[0070] One or more neuromodulation leads of the lead system 518 can be placed near the dorsal root tissue to be stimulated (e.g., near or adjacent to the dura mater). Due to the lack of space near the location of the implanted one or more neuromodulation leads, the implantable modulation device 512 can be implanted in a surgical pocket above the abdomen or buttock, or in other locations on the patient's body. One or more lead extensions can be used to facilitate implantation of the implantable modulation device 512 away from the exit point of the one or more neuromodulation leads.
[0071] Figure 6An embodiment of an SCS system, also known as a Spinal Cord Modulation (SCM) system, is illustrated by way of example. The SCS system 625 typically includes one or more (two illustrated) implantable neuromodulation leads 626, an implantable pulse generator (IPG) 627, an external remote controller (RC) 628, a clinician's programmer (CP) 629, and an external experimental modulator (ETM) 630. The IPG 627 can be physically connected to the neuromodulation leads 626 carrying multiple electrodes 632 via one or more percutaneous lead extensions 631. When the electrodes are implanted in a patient, an electrode arrangement is formed. As shown, the neuromodulation leads 626 can be percutaneous leads, with the electrodes arranged in a straight line along the neuromodulation leads. Any suitable number (including one) of neuromodulation leads can be provided to allow for lateral current redirection, as long as the number of electrodes is greater than two (including the IPG housing function as housing electrodes). Alternatively, surgical paddle wires can be used instead of one or more percutaneous leads. The IPG627 includes a pulse generation circuit that delivers electrically modulated energy to the electrodes in the form of pulsed electrical waveforms (i.e., a time sequence of electrical pulses) according to a set of modulation parameters.
[0072] The ETM 630 can also be physically connected to one or more neural modulation leads 626 via a percutaneous lead extension 633 and an external cable 634. The ETM 630 may have a pulse generation circuit similar to that of the IPG 627 to deliver electrically modulated energy to the electrodes according to a set of modulation parameters. The ETM 630 is a non-implantable device that can be tested after implantation of the neural modulation leads 626 and before implantation of the IPG 627 to test the responsiveness of the modulation to be provided. The functionality described herein for the IPG 627 can also be performed for the ETM 630.
[0073] The RC 628 can be used to telemetry control the ETM 630 via a bidirectional RF communication link 635. The RC 628 can also be used to telemetry control the IPG 627 via a bidirectional RF communication link 636. This control allows the IPG 627 to be turned on or off and programmed with different sets of modulation parameters. The IPG 627 can also be operated to modify the programmed modulation parameters to actively control the characteristics of the electrically modulated energy output by the IPG 627. Clinicians can use the CP 629 to program the modulation parameters into the IPG 627 and ETM 630 in the operating room and in subsequent sessions.
[0074] CP 629 can communicate indirectly with IPG 627 or ETM 630 via RC 628, through IR communication link 637 or other links. CP 629 can also communicate directly with IPG 627 or ETM 630 via RF communication link or other links (not shown). The detailed modulation parameters provided by CP 629 can also be used to program RC 628, allowing the modulation parameters to be subsequently modified by operating RC 628 in stand-alone mode (i.e., without the assistance of CP 629). Various devices can be used as CP 629. Such devices can include portable devices such as laptops, minicomputers, personal digital assistants (PDAs), tablets, telephones, or remote controls (RCs) with extended capabilities. Therefore, the programming method can be performed by executing software instructions contained within CP 629. Alternatively, firmware or hardware can be used to perform this programming method. In any case, CP 629 can actively control the characteristics of the electrical modulation generated by IPG 627 to allow the determination of desired parameters based on patient feedback or other feedback, and to subsequently program IPG 627 with the desired modulation parameters. To allow the user to perform these functions, CP 629 may include user input devices (e.g., a mouse and keyboard) and a programming display screen housed within a housing. In addition to or in place of a mouse, other directional programming devices may be used, such as a trackball, touchpad, joystick, touchscreen, or directional keys included as part of the keys associated with the keyboard. External devices (e.g., CPs) can be programmed to provide one or more displays that, among other functions, allow clinicians to select or input patient profile information (e.g., name, date of birth, patient identity, physician, diagnosis, and address), input procedural information (e.g., programming / follow-up, implantation of a trial system, implantation of an IPG, implantation of an IPG and one or more leads, replacement of an IPG, replacement of an IPG and leads, replacement or modification of leads, explants, etc.), generate a patient pain map, define lead configuration and orientation, initiate and control the electrically modulated energy output of the neuromodulation leads, and select and program the IPG using modulation parameters (including electrode selection) in surgical and clinical settings. One or more displays can be used to suggest one or more electrodes for stimulating the target dorsal root. One or more external devices (e.g., CPs and / or RCs) can be configured to communicate with one or more other devices, including one or more local devices and / or one or more remote devices. For example, wired and / or wireless communications can be used for communication between or within devices.
[0075] The external charger 638 can be a portable device for percutaneous charging of the IPG via a wireless link (such as inductive link 636). Once the IPG has been programmed and its power has been charged by the external charger or otherwise fully charged, the IPG can operate as programmed without the presence of RC or CP.
[0076] Figure 7 Some features of the neural modulation lead 726 and pulse generator 727 are illustrated by way of example. The pulse generator 727 may be an implantable device (IPG) or an external device, such as one used to test electrodes during an implantation procedure. In the example shown, the neural modulation lead has eight electrodes 732 (labeled E1-E8). The actual number and shape of the leads and electrodes may vary depending on the intended application. The implantable pulse generator (IPG) may include a housing for housing electronics and other components. The housing may be made of a conductive, biocompatible material (such as titanium) that forms a sealed compartment in which the internal electronics are protected from the effects of body tissue and fluids. In some cases, the housing may serve as electrodes (e.g., housing electrodes). The IPG may include electronic components such as a controller / processor (e.g., a microcontroller), memory, a battery, telemetry circuitry, monitoring circuitry, modulation output circuitry, and other suitable components known to those skilled in the art. The microcontroller executes a suitable program stored in memory to direct and control the neural modulation performed by the IPG. Electrically modulated energy is provided to the electrodes according to a set of modulation parameters programmed into the pulse generator. The electrically modulated energy may be in the form of a pulsed electrical waveform. These modulation parameters may include electrode combinations that define the electrodes activated as anodes (positive), cathodes (negative), and off (zero), the percentage of modulation energy allocated to each electrode (a detailed electrode configuration), and electrical pulse parameters that define the pulse amplitude (which can be measured in milliamperes or volts, depending on whether the pulse generator provides a constant current or a constant voltage to the electrode array), the pulse width (which can be measured in microseconds), the pulse rate (which can be measured in pulses per second), and the burst rate (which can be measured as modulation on duration X and modulation off duration Y). Electrodes selected to transmit or receive electrical energy are referred to herein as “active,” while electrodes not selected to transmit or receive electrical energy are referred to herein as “inactive.”
[0077] Electrical modulation occurs between multiple activating electrodes, one of which may be the IPG housing. The system is capable of delivering modulated energy to the tissue in a unipolar or multipolar (e.g., bipolar, tripolar, etc.) manner. Unipolar modulation occurs when a selected lead electrode is activated along with the IPG housing, causing modulated energy to transfer between the selected electrode and the housing. Any of the electrodes E1-E8 and the housing electrode can be assigned to up to k possible groups or timing “channels.” In one embodiment, k can be equal to four. The timing channels identify which electrodes are selected to synchronously provide or absorb current to generate an electric field in the tissue to be stimulated. The amplitude and polarity of the electrodes on the channels can vary. Specifically, in any of the k timing channels, the electrode can be selected as positive (anode, source current), negative (cathode, absorb current), or off (no current). IPGs can operate in a mode that delivers electrically modulated energy that is therapeutically effective and perceptible to the patient (e.g., therapeutically effective to relieve pain with perceived sensory abnormalities), and can operate in a sub-perceptual mode to deliver electrically modulated energy that is therapeutically effective and perceptible to the patient (e.g., therapeutically effective to relieve pain without perceptible sensory abnormalities).
[0078] IPGs can be configured to individually control the magnitude of the current flowing through each electrode. For example, a current generator can be configured to selectively generate individually regulated current amplitudes from independent current sources for each electrode. In some embodiments, the pulse generator may have a voltage-regulated output. While individually programmable electrode amplitudes are desirable for fine control over the shape and size of the resulting modulation field, a single output source that switches across electrodes can also be used, albeit with less fine control in programming. Neural modulators can be designed with hybrid current and voltage regulation devices.
[0079] For the convenience of readers, Figure 8 Partial views of the neuroanatomical and bony anatomy of the spine are shown. The neuroanatomy includes the spinal cord 100 as shown in Figure 1. The neuroanatomy also includes the dorsal horn (DH) 104, dorsal root 105, DRG 106, ventral root 107, and mixed spinal nerve root 108. The bony anatomy refers to the vertebrae comprising the vertebral bodies 839 and bony rings 840 attached to the vertebral bodies 839. The stacked vertebrae provide the vertebral canal protecting the spinal cord 100. Nerve roots bifurcate and exit the spine laterally through the spaces between the vertebrae (“intervertebral foramina”). The spinal cord is surrounded by the dura mater 841, which holds the cerebrospinal fluid surrounding the spinal cord 100. The space between the walls of the vertebral canal and the dura mater is referred to as the epidural space 842.
[0080] Figures 9A-9CThe transverse top view, coronal lateral view, and angled view of the spinal cord 100, dorsal root 105, DRG 106, ventral root 107, and mixed spinal nerve root 108 are shown respectively. Figure 9A Also shown are bone 943, fat 944, dura mater 945, and cerebrospinal fluid 946.
[0081] Figure 10A-10G This is a schematic diagram of an embodiment where a neuromodulation lead is placed on the patient's spinal cord. Specifically, Figure 10A This is a schematic diagram of a single electroneurometric lead 1039 implanted in the approximate longitudinal midline of the spinal cord 100. It should be understood that additional leads or one or more lead paddles may be used, such as those that can be used to provide a wider electrode arrangement and / or to provide electrodes closer to the dorsal horn unit, and these electrode arrays may also implement subdivided currents. Figure 10B An embodiment of implanting two electroneurometric modulated leads near the spinal cord is shown. The first electroneurometric modulated lead 1041 is implanted more laterally relative to the spinal cord, thereby placing it close to the dorsal horn of the spinal cord. The second electroneurometric modulated lead 1042 is implanted more centrally relative to the spinal cord, thereby placing it close to the dorsal column of the spinal cord 100.
[0082] Placing the leads closer to the dorsal root (DH) than the dorsal root (DC) may be to preferentially stimulate DH units rather than DC units for subsensory therapy. Lead placement may also preferentialize dorsal root neural modulation over other units. Multiple leads or multiple rows of paddle leads can also be used. The longitudinal component of the electric field runs along... Figures 10A-10B In each of the diagrams, the y-axis is pointed, and the transverse component of the electric field is along... Figures 10A-10B The x-axis depicted in each of the diagrams is pointed to. Some embodiments may include a oriented lead with one or more oriented electrodes. The oriented electrodes may extend less than 360 degrees around the circumference of the lead body. For example, a row of two or more oriented electrodes (e.g., “segmented electrodes”) may be positioned along the circumference of the lead body. Activating selected electrodes in the segmented electrodes can help extend and shape the field in a preferred direction.
[0083] It is understood that the same or different types of additional neural modulation leads or one or more paddles can be used, such as those that can be used to provide a wider electrode arrangement and / or to provide electrodes closer to the dorsal horn unit. In some examples, the neural modulation leads or paddles may be placed in a region more caudal at the end of the spinal cord, and the electrode array on the neural modulation leads may also implement subdivided currents. Figure 10C-10G This is a schematic diagram of an embodiment where a neural modulation lead is placed in the caudal region of the spine, such as the L3-L5 and S1 segments, where the spinal cord is almost absent, and only the dorsal roots and other neural structures are present. The neural modulation lead, or paddle, can be placed midway or laterally in the spine, close to one or more dorsal roots, and is configured to deliver modulated energy to the dorsal root fibers. Figure 10C In the middle, three percutaneous guides 1010 are positioned towards the left side of the spinal canal, and in Figure 10D In the middle, two percutaneous guides 1020 are positioned towards the left side of the spinal canal. Figure 10E In the middle, a single four-row paddle-shaped guide 1030 is positioned towards the left side of the spinal canal, and... Figure 10F In the middle, a single two-row paddle-shaped guide wire 1040 is positioned towards the left side of the spinal canal. Figure 10G In this example, a single percutaneous lead 1050 is positioned toward the left side of the spinal canal. In the illustrated example, the percutaneous lead 1050 includes multiple segmented electrodes, which enable lateral control of the stimulation location via a single lead. Furthermore, because the segmented electrodes are positioned very close to the lateral direction, they can be used to provide high lateral stimulation resolution.
[0084] Although Figure 10C-10G The examples shown depict electrode leads placed on the left side of the spinal canal, but these are merely examples and not limitations. Figure 10C-10G In any of these cases, a lead placement on the right side of the spinal canal can also be used. As can be seen from the figures, different types of leads (including the different types shown) with varying numbers of electrodes and different electrode spacings can be used to provide dorsal root stimulation. These example lead placements differ from the lead placement closer to the anatomical midline in conventional spinal cord stimulation (SCS) therapy.
[0085] Figure 10C-10G The dorsal root tracks 1002A and 1002B show that dorsal root fibers have different tracks than dorsal column fibers, and they are not aligned with the anatomical midline. Therefore, the relative position (e.g., the angle of entry of the lead-in fibers) between the lead-in fibers and the neural target (e.g., dorsal column fibers or dorsal root fibers) can vary in different anatomical regions, such as... Figure 10C-10G As shown. When neural modulation is specifically targeted at dorsal root fibers, the location of the dorsal roots is required so that stimulation can be customized. This document describes various embodiments of incorporating anatomical information of the target neural tissue (e.g., the trajectory of the dorsal roots) and patient feedback on sensory abnormalities into the stimulation field design process. This can help improve the accuracy of neural modulation and thus achieve better therapeutic outcomes, such as pain relief.
[0086] Figure 10H These are schematic diagrams of the electrical neural modulation lead 1043, illustrating a breakdown example of the anodic current delivered to the electrodes on the electrical neural modulation lead. These diagrams show a breakdown using unipolar neural modulation, where the IPG's housing electrode is the sole cathode and carries 100% of the cathode current. Figure 10EThe subdivision of the anodic current shown does not deliver an equal amount of current to each electrode 1044 because this embodiment takes into account differences in electrode / tissue coupling, i.e., differences in how the tissue beneath each electrode responds to electrical neuromodulation. Furthermore, the ends of the portion of the electrical neuromodulation lead include electrodes with a lower gradient in the longitudinal direction. The magnitude of the electric field gradually decreases at the ends of the electrical neuromodulation lead. The subdivision of the current can accommodate variations in the tissue beneath those electrodes. The subdivision of the electrical neuromodulation lead can be varied in any way as long as the sum of the subdivision currents equals 100%. The various embodiments described herein implement a programming algorithm to determine the appropriate subdivision to achieve the desired neuromodulation field characteristics.
[0087] Neural modulation thresholds vary depending on the patient and the electrodes within the patient's body. Electrode / tissue coupling calibration can be performed on the electrodes to interpret these different neural modulation thresholds and provide a more accurate breakdown of the current between the electrodes. For example, a sensory threshold or neural threshold (also known as an evoked compound action potential (ECAP) threshold) can be used to normalize the electrodes. In this case, the ECAP threshold under consideration could be a back root threshold, and the system could have physiological sensing and signal processing capabilities to analyze the recorded signals and determine the minimum amplitude that triggers the presence of an ECAP. The minimum amplitude thus determined can represent the neural or ECAP threshold. The RC or CP can be configured to prompt the patient to actuate the control unit once the patient perceives a sensory abnormality. In response to this user input, the RC or CP can be configured to respond to the user input by storing the neural modulation signal strength when the control unit is actuated. Other sensing parameters or patient-perceived neural modulation values (e.g., constant sensory abnormality or maximum tolerated sensory abnormality) can be used to provide electrode / tissue coupling calibration for the electrodes.
[0088] The SCS system can be configured to deliver different electric fields to achieve a temporal summation of neural modulation. The electric fields can be generated separately on a pulse-by-pulse basis. For example, a first electric field can be generated by electrodes (using a first current subdivision) during the first electrical pulse of the pulse waveform, a second different electric field can be generated by electrodes (using a second different current subdivision) during the second electrical pulse of the pulse waveform, a third different electric field can be generated by electrodes (using a third different current subdivision) during the third electrical pulse of the pulse waveform, a fourth different electric field can be generated by electrodes (using a fourth different current subdivision) during the fourth electrical pulse of the pulse waveform, and so on. These electric fields can be rotated or cycled multiple times under a timing scheme, where each field is implemented using a timing channel. The electric fields can be generated at a continuous pulse rate or burst intermittently. Furthermore, the inter-pulse interval (i.e., the time between adjacent pulses), pulse amplitude, and pulse duration during the electric field period can be uniform or can vary within the electric field period.
[0089] Some embodiments are configured to determine a set of neural modulation parameters to create a stimulation field definition that reduces or minimizes neural modulation of non-target tissues, such as dendritic (DH) tissue. The neural modulation field can be shaped using multiple independent current control (MICC) or multiple independent voltage control to guide the estimation of current subdivision between multiple electrodes and to estimate the total amplitude providing the desired intensity. For example, the neural modulation field can be shaped to enhance neural modulation of DH tissue and minimize neural modulation of DH tissue. One advantage of MICC is that it takes into account electrode-tissue coupling efficiency and the difference in sensory thresholds for each individual contact, thereby eliminating “hot spot” stimulation.
[0090] Figure 11A-11B A schematic diagram of an embodiment in which a neural modulation lead is placed on a patient's spinal cord is shown by way of example and not limitation. Figure 11A An epidural midline guide 1110 targeting the back column 103 is shown. The midline epidural guide 1110 may or may not provide desired coverage of the focal pain area, and may or may not provide stimulus spillover. Furthermore, finding a setting that covers both lower back pain and focal pain can be challenging. Figure 11B Lateral dural lead 1120 is shown. According to the various examples discussed herein, lateral dural lead 1120 can provide more effective stimulation to lateral spinal nerve targets, such as dorsal root 105, dorsal branch root 109, or DREZ 119.
[0091] One aspect of the embodiments discussed in this document involves automatically identifying lateral spinal nerve targets corresponding to epidural lead placement and focal pain areas, and generating a set of optional treatment options, such as electrode configurations for nerve stimulation. Focal pain areas can be identified by the patient using a pain map. Figure 12A and Figure 12B This is a diagram illustrating, by way of example and not limitation, the anatomical regions on a patient's body where pain is felt (pain sites) or the anatomical regions on a patient's body where the effects of nerve stimulation delivery (such as paresthesia) are perceived (paresthesia sites). Anatomical sites can be drawn (e.g., by the patient freehand), derived from the patient's pain drawing or paresthesia diagram via a lookup table or algorithm, or a combination of such methods. Figure 12A Figure 1200 shows an example of a target site on a representation of multiple electrodes implanted in a patient's body. The target site may be a pain site (in which case, Figures 1200, 1210, and 1220 are referred to as pain maps) or a paresthesia site (in which case, Figures 1200, 1210, and 1220 are referred to as paresthesia maps). Figure 12B A diagram representing a site of pain or paresthesia on a schematic depiction of one or two bodies, including the abdomen and back, is shown by way of example, not limitation. In the example shown, the site of pain or paresthesia is marked on the abdominal depiction of the body in the first figure 1210 and on the back depiction of the body in the second figure 1220. Pain maps and paresthesia maps can be generated separately and provided to a neural modulation control system. In one example, the site of pain or paresthesia can be mapped to a specific dermal area on the skin. The mapping can be a point-by-point mapping via a lookup table or dictionary / key system. The center, length, and width of the target linear field can be determined based on the spatial extent of the spinal cord region corresponding to the area of pain reported by the patient. A combination of clinicians or other specialists, patients, or individuals can work together to highlight the areas of the spinal cord and / or body they want to stimulate as targets (i.e., to focus stimulation on anatomically relevant and / or reported sites of pain). An internal lookup table and / or reverse algorithm with fields “primitives” associated with the size of a specific region / region can be used to display and configure electrode settings according to this anatomical-based specification.
[0092] Figure 13 This diagram broadly illustrates an example of dermatomes in the human body and their corresponding spinal nerves originating from the spinal cord. Originating from the spinal cord are eight cervical nerves (C1 to C8), twelve thoracic nerves (T1 to T12), five lumbar nerves (L1 to L5), and five sacral nerves (S1 to S5). Each of these nerves transmits sensations, including pain, from a specific area of the skin to the brain. Successful pain management and avoidance of stimulation of unaffected areas require the applied electric field to be correctly positioned longitudinally along the spinal cord and nearby structures.
[0093] A dermatome is a skin region supplied by sensory neurons generated by the ganglia of a spinal nerve at a given spinal cord segment. A total of 29 spinal nerves (including cervical nerves C2-C8, thoracic nerves T1-T12, lumbar nerves L1-L5, and sacral nerves S1-S5) can be mapped to corresponding dermatomes, resulting in 29 dermatomes distributed across the body surface, except for the cervical nerve C1, which is not mapped to a dermatome. Specifically, the head and neck region is associated with C2-C8, the back with C2-S3, the central diaphragm with C3-C5, the upper limbs with C5-T1, the chest wall with T1-T11, the peripheral diaphragm with T6-T11, the abdominal wall with T6-L1, the lower limbs with L2-S2, and the perineum with L4-S4. For example, chronic pain is often concentrated in the lower back and lower limbs, corresponding to T8-T10. Specific energy fields can be applied to the corresponding spinal nerves to treat chronic pain in that area.
[0094] Figure 14A block diagram of a neuromodulation system 1400 is shown by way of example and not limitation, configured to provide optional lateral spinal cord stimulation (SCS) for pain control. The neuromodulation system 1400 is an embodiment of the neuromodulation system 210 and may include one or more of a user interface 1410, controller circuitry 1430, and an electrical stimulator 1440. A portion of the neuromodulation system 1400 may be implemented in an implantable system 521 or an external system 522. In one example, the user interface 1410 and controller circuitry 1430 may be included in a programming device, such as programming device 413.
[0095] User interface 1410 is an example of GUI 414, including user input unit 1411 and output unit 1412. User input unit 1411 may include one or more user interface (UI) controls that can be used by a user to provide information about lead placement 1413. Lead placement 1413 may include selection from a variety of lead types, including, for example, percutaneous cylindrical leads, linear blades, multi-row blades, or oriented leads with segmented electrodes (hereinafter collectively referred to as "leads"), and placing the selected one or more leads at corresponding positions on a graphical representation of the spinal cord displayed on user interface 1410, such as... Figures 10A-10F and Figure 11A-11B As shown. See below for reference. Figure 15A and Figure 16A Describe an example of placing one or more leads on a graphical representation of the spinal cord.
[0096] User input unit 1411 can receive patient pain data 1414. Patient pain data 1414 may include indications of the anatomical location (pain site) of the pain perceived by the patient. Patient pain data 1414 may also include one or more of the following: pain distribution, pain intensity or time patterns (such as pain duration at various pain sites), and other pain information. Patient pain data 1414 can be represented by text, graphs, verbal descriptions, and other representations. In one example, patient pain data 1414 includes a pain graph, such as... Figure 12A-12B The pain map shown is a pain map. The pain map may include pain markers provided by the patient, which identify the locations where pain radiates or extends. The pain markers may additionally include different symbols to distinguish various pain sensations, such as aching, numbness, burning, tingling, or pinprickling. Additionally or alternatively, the pain markers may include different symbols to distinguish various pain intensities at each marked pain location. In some examples, patient pain data 1414 may include a patient questionnaire or patient pain description. In some examples, patient pain data 1414 may include reference data, such as a dermatome map, which identifies (e.g., using labels, markings, or annotations) various dermatome regions corresponding to the spinal nerves innervating the said dermatome region, such as… Figure 13 As shown in the image. This pain-related dermal area is called a pain dermatome and can be automatically identified. See below for reference. Figure 15A Examples of patient pain data 1414, such as patient pain maps and pain dermatomes.
[0097] Controller circuit 1430, as an example of programmable control circuit 420, can determine optimal pain treatment, including electrode configuration for delivering nerve stimulation. Controller circuit 1430 may include a circuit set comprising one or more other circuits or sub-circuits, such as a neural target recognizer 1431, a stimulation pattern circuit 1432, and a stimulation controller 1433. The circuits or sub-circuits may perform the functions, methods, or techniques described herein individually or in combination. In one example, the hardware of the circuit set may be invariably designed to perform a specific operation (e.g., hardwired). In one example, the hardware of the circuit set may include physically connected components (e.g., execution units, transistors, simple circuits, etc.), including physically modified computer-readable media (e.g., magnetic, electrical, movable placement of invariant aggregated particles, etc.) to encode instructions for a specific operation. When connecting physical components, the basic electrical characteristics of the hardware components are changed, e.g., from insulator to conductor, and vice versa. Instructions enable embedded hardware (e.g., execution units or loading mechanisms) to create members of the circuit set in the hardware via variable connections to perform portions of a specific operation during operation. Therefore, while the device is operating, the computer-readable medium is communicatively coupled to other components of a circuit set member. In one example, any physical component may be used in more than one member of more than one circuit set. For example, under operation, an execution unit may be used in a first circuit of a first circuit set at one point in time and reused at different times by a second circuit of the first circuit set or a third circuit of the second circuit set.
[0098] In various examples, some functions of the controller circuitry 1430 may be implemented as part of a microprocessor circuit. The microprocessor circuit may be a special-purpose processor, such as a digital signal processor, an application-specific integrated circuit (ASIC), a microprocessor, or other type of processor for processing information including bodily activity information. Alternatively, the microprocessor circuit may be a general-purpose processor that can receive and execute a set of instructions for performing the functions, methods, or techniques described herein.
[0099] The neural target recognizer 1431 can identify one or more neural targets based at least on information regarding the placement of the lead 1413. As an example, and not a limitation, this applies to leads placed near the lateral portion of a particular spinal cord segment (such as...). Figure 11BAs shown in the graphic representation of the spinal cord (lateral dural lead 1120), the neural target recognizer 1431 can identify corresponding lateral spinal cord targets, such as the dorsal root 105, dorsal ramus root 109, or DREZ 119 at the spinal cord segment where the lead is placed. In some examples, lead placement 1413 may include placing multiple leads at corresponding portions (e.g., lateral portions) of the graphic spinal cord representation. Each lead includes an array of electrodes that dock with the spinal cord at a corresponding electrode-tissue contact. The neural target recognizer 1431 can generate one or more groups of contacts. Each group of contacts includes multiple electrode-tissue contacts associated with electrodes on the same lead or electrodes on two or more different leads. The groups of contacts may be located at different locations on the spinal cord. For a group of contacts, the neural target recognizer 1431 can identify the corresponding spinal cord target based on the location of the electrode-tissue contacts in that group of contacts. Figure 15B In the example shown, the first contact group may correspond to a first lateral spinal nerve target, including the dorsal column, dorsal root, DREZ, dorsolateral tract, and inhibitory interneuron; the second contact group may correspond to a second lateral spinal nerve target including one or more midline dorsal roots; and the third contact group may correspond to a third lateral spinal nerve target including one or more lateral dorsal roots.
[0100] The neural target recognizer 1431 can further identify one or more neural targets based on patient pain data 1414, such as one or more pain regions or corresponding one or more pain dermatomes (user input), and detect the neural threshold of each contact or group of contact during stimulation mapping. In one example, the neural target recognizer 1431 can determine the cephalo-caudal and / or intermediate-lateral position of the contact group relative to one or more spinal cord segments innervating the dermatome corresponding to the pain region (pain dermatome), and identify the neural target of interest based on whether the electrode-tissue contact of the contact group is located at the spinal cord segment of the pain dermatome or at the cephalo- or caudal end of the spinal cord segment of the pain dermatome. (See below for further details.) Figure 15B This section describes examples of generating different contact groups, identifying the corresponding neural targets for each contact group, and displaying them on a user interface.
[0101] In addition to or instead of automatic identification of neural targets based on user input of lead placement 1413 and optional patient pain data 1414, in some examples, the user (e.g., a clinician or other caregiver and / or patient) may manually identify one or more neural targets, such as by selecting from a pre-generated list of candidate neural targets via user input unit 1411 of user interface 1410. See below. Figure 16B-16D This section discusses examples of manually selecting neural targets on a user interface.
[0102] The stimulation pattern circuit 1432 can generate optional electrical stimulation settings for spinal nerve targets, such as lateral spinal nerve targets automatically identified by the nerve target recognizer 1431, or lateral spinal nerve targets manually selected by the user. The electrical stimulation settings may include stimulation patterns that indicate electrode configurations (e.g., monopolar, bipolar, or tripolar stimulation, anode and cathode designation). The electrical stimulation settings may include the location of a stimulation center point indicating the focus of the stimulation field. The electrical stimulation settings may additionally or alternatively include one or more stimulation parameters, such as current or voltage amplitude, pulse width, pulse shape (waveform), pulse rate, duty cycle, any other static parameter, or a modulated waveform that continuously adjusts the amplitude, pulse width, or frequency of the pulse train, wherein the modulated waveform may be a random signal, sine wave, triangular wave, exponential wave, logarithmic wave, quadratic wave, or any other modulation function, and the function parameters may be other parameters including those listed herein.
[0103] Optional electrical stimulation settings can include stimulation patterns based on sensory abnormalities, which can induce sensory abnormalities during stimulation. Examples of stimulation patterns based on sensory abnormalities include monopolar stimulation, bipolar stimulation, tripolar stimulation, turning, sensory, and rotational stimulation. The stimulation can be cathodic or anodic. In one example, monopolar anodic stimulation can be applied after searching through different electrode-tissue contacts using a MICC. In one example, monopolar anodic stimulation can be applied with time-varying pulses (TVPs), such as a rate, pulse width, or amplitude defined as modulated by a specific function, such as a sine wave function, a random function following a statistical distribution (e.g., a Poisson distribution or a uniform distribution), or other arbitrary waveform. TVP with monopolar anodic stimulation can be applied after searching for the sweet spot using a MICC through different contacts. The sweet spot is the ideal or optimal location of the neural modulation field. In one example, a test area can be induced with a subsensory neural modulation field, and when subsensory neural modulation is targeted, the sweet spot can be identified as therapeutically effective neural tissue. Sweet spot testing may involve a manual process of reprogramming the neural modulation field parameter set with different values to alter the target location of the neural modulation field. In some embodiments of the test, the target location can be automatically altered (e.g., dragged) by automatically changing the values of the neural modulation field parameter set. Some embodiments may semi-automatically change the values of the neural modulation field parameter set to alter the target location of the neural modulation field. In one example, monopolar cathode stimulation can be applied with or without TVP. In another example, bipolar stimulation can be applied with or without TVP. The bipolar configuration includes an anode located at the root and a cathode located in the middle lead. In one example, tripolar stimulation can be applied in a head-to-tail direction. In some examples, shunt cathodes can be used in a MICC manner to make the anode stimulation more localized (e.g., along the head-to-tail and middle-to-lateral directions). Because the branch root extends at this point, the cathode can be used to shunt the anode current of a branch root that does not correspond to the branch root of interest. In one example, a long head-to-tail anode monopole can be used to excite a larger area of the DREZ.
[0104] Optional electrical stimulation settings may include stimulation modes that do not typically induce paresthesia at the stimulator. Examples of paresthesia-free stimulation modes include Fast-Acting Sub-perception Therapy (FAST) mode, Dorsal Horn Modulation (DHM) mode, burst mode, and Low-Rate Active Recharge (LRAR) mode. FAST mode allows the delivery of stimulation pulses to provide deep, paresthesia-free pain relief over a short period (e.g., several minutes) by increasing circumferential inhibition. DHM is a stimulation mode that can target inhibitory interneurons on dorsal column fibers. In LRAR mode, sub-perception stimulation pulses are delivered at a lower frequency than typical DHM.
[0105] In some examples, the stimulation pattern circuit 1432 can generate multiple CPSs based on the lead placement. Each CPS represents the focal point of a stimulation field established by stimulation energy applied to an electrode on a portion of the epidural lead. The stimulation fields corresponding to multiple CPSs can activate corresponding spinal cord targets at different spinal cord segments. To generate multiple CPSs, the user can program the corresponding electrodes on the lead with appropriate stimulation patterns and parameters based on sensory abnormalities or the absence of sensory abnormalities. See below. Figures 17A-17B Examples of programming stimulation patterns and parameters for electrodes on different parts of the leads for multiple CPS are discussed.
[0106] The stimulation pattern circuit 1432 can generate corresponding optional electrical stimulation settings for one or more contact groups generated by the neural target recognizer 1431. The optional electrical stimulation settings for one contact group can differ from those for another. In one example, two different contact groups can have at least one common electrical stimulation setting (e.g., anodic stimulation). In one example, the stimulation pattern circuit 1432 can generate multiple candidate stimulation patterns based on sensory abnormalities and multiple candidate stimulation patterns without sensory abnormalities for a contact group. A user can select from the sensory abnormality-based stimulation patterns and / or the non-sensory abnormality secondary patterns for a given contact group via the user input unit 1411 of the user interface 1410. Based on the selected stimulation pattern, the user can program one or more stimulation parameters, such as current or voltage amplitude, pulse width, pulse shape (waveform), pulse rate, or duty cycle. The stimulation patterns and stimulation parameters corresponding to the contact groups can be stored in a storage device, such as the storage device 419 of the programming device 413. (Refer to below...) Figure 15C-15E and Figure 16B-16DThe discussion includes examples of selecting stimulus patterns based on sensory abnormalities or those without sensory abnormalities, as well as programming stimulus parameters on a user interface.
[0107] The stimulation controller 1433 can generate control signals for adjusting stimulation settings, such as by dragging the CPS position or adjusting one or more stimulation parameters (e.g., pulse width, amplitude, duty cycle, stimulation rate, modulation frequency, modulation depth, etc.). The control signals can trigger the electrical stimulator 1440 to deliver pain-relieving neurally modulated energy at one or more lateral spinal nerve targets (e.g., automatically identified by the nerve target recognizer 1431 or manually selected by the user), based on user-selected electrical stimulation settings (such as those provided by the stimulation mode circuitry 1432). The electrical stimulator 1440 can be an implantable module, such as being incorporated into an implantable system 521. Alternatively, the electrical stimulator 1440 can be an external stimulation device, such as being integrated with an external system 522.
[0108] In some examples, stimulation controller 1433 may control electrical stimulator 1440 to generate electrical stimulation energy to individually and independently stimulate each of the two or more identified lateral spinal nerve targets, based on electrical stimulation settings (e.g., stimulation modes and stimulation parameters) determined or selected for each of the two or more identified lateral spinal nerve targets. The patient may provide feedback, such as via user interface 1410, regarding pain relief in response to electrical stimulation at the two or more identified candidate nerve targets. Based on patient feedback, stimulation controller 1433 may select a “best” nerve target from the two or more identified candidate nerve targets, such as the one with the most significant pain relief effect. In some examples, stimulation controller 1433 may sort the two or more identified candidate nerve targets in ascending or descending order of pain relief effect. Electrical stimulator 1440 may be programmed to deliver clinical pain treatment (e.g., chronic pain stimulation) to the selected “best” nerve target according to the corresponding stimulation settings. The identified candidate neural targets and optimal neural targets, along with their corresponding stimulation patterns and stimulation parameters, can be stored in a storage device, such as storage device 419 of programming device 413.
[0109] Depending on the choice of stimulation pattern based on sensory abnormalities or non-sensory abnormalities, the neural stimulation for pain relief can be extrasensory or subsensory. Stimulation energy can be delivered using monophasic stimulation pulses applied to each electrode, which, depending on the subdivision configuration, can serve as either an anode or a cathode. Alternatively, biphasic stimulation pulses can be used to deliver stimulation energy. Each biphasic pulse has a first phase of a first polarity, followed by a second phase of a second polarity opposite to the first polarity. The first and second phases can be symmetrical (e.g., of the same amplitude or duration). Alternatively, the first and second phases can be asymmetrical. Because the two phases in the stimulation pulse have opposite polarities, the electrode polarity (i.e., designating the electrode as an anode or cathode) will reverse as the stimulation current changes from the first phase to the second phase. In one example, the cathode and anode names can be modified based on the first phase of the biphasic pulse. For example, if the first phase is positive, the already determined anode and cathode are not modified. If the first phase is negative, the anode and cathode names are interchanged. In one example, asymmetrical biphasic stimulation can be delivered to preferred stimulation sites and sites to be avoided. In preferred stimulation sites, biphasic stimulation may include a first anodic phase with a longer duration and a smaller amplitude, followed by a second cathodic phase with a shorter duration and a larger amplitude. In areas to be avoided, biphasic stimulation may include a first cathodic phase with a longer duration and a smaller amplitude (subthreshold of its pulse width), followed by a second anodic phase with a shorter duration and a higher amplitude, for charge balancing.
[0110] Figure 15A-15F The user interface for programming the optional lateral SCS for pain control is shown as an example. Figure 15A In the middle, a pain map 1510 is shown, depicting a human body with pain areas 1511 and 1512 identified by the patient (similar to...). Figure 12B The pain map shown can be provided by the user or patient, such as through UI controls on the user interface. Markings of dermatomes can be included in the human anatomy map to provide a visual representation of the pain dermatomes corresponding to the patient-identified pain areas 1511 and 1512. The patient-identified pain areas and pain dermatomes can be used to identify spinal nerve targets and / or to generate a list of optional electrical stimulation settings such as stimulation patterns. For this reason, as... Figure 15A-15F The SCS programming method described in the text is also known as the "Pictorial Mode". Figure 15AThe user interface can also display one or more lead types with different sizes, lengths, shapes, or electrode numbers and arrangements, such as the first type cylindrical lead 1513A, the second type cylindrical lead 1513B (longer than the first type lead 1513A and with more electrodes), and the paddle-shaped lead 1513C, etc. In some examples, two or more leads of the same or different types (e.g., percutaneous leads or cylindrical leads) can be combined to form a curved lead 1513D. In one example, the curved lead 1513 includes two or more cylindrical lead segments arranged at an angle relative to each other. The curved lead 1513D can include multiple electrodes laterally in the intervertebral foramen and epidural space. The curved lead 1513D can provide more effective and focused stimulation to lateral spinal cord targets with complex anatomy.
[0111] Users can select the type of lead (such as by clicking on the lead image) and move or apply it to the desired location in the graphical spinal cord representation 1514. As an example, Figure 15A The diagram illustrates the placement of a first-type cylindrical lead 1513A at segment T11-T12, a second-type cylindrical lead 1513B at segment T12-L2, and a curved lead 1513D at segment L1-L3, the curved lead 1513D comprising three first-type cylindrical leads 1513A connected in series at a specific angle relative to each other. Figure 1515 shows the placement of all leads across the spinal cord anatomy on a user interface.
[0112] Figure 15B A user interface is shown, displaying spinal nerve targets automatically identified based on user input of pain regions on pain map 1510 and lead placement as shown in 1514 and 1515. Identification of spinal nerve targets can be activated using UI control buttons, such as by clicking the "Calculate Target" button 1516. Spinal nerve targets can be... Figure 14 The neural target recognizer 1431 identifies the target. As described above, the neural target recognizer 1431 can generate one or more contact groups, each contact group including a plurality of corresponding electrode-tissue contacts associated with electrodes on the same lead or two or more different leads. Figure 15B The first contact group 1522, the second contact group 1524, and the third contact group 1526 are shown by way of example, not limitation. The contact groups can be distinguished by different colors or presentations displayed on the user interface. For example, the first contact group 1522 could be displayed in yellow, the second contact group 1524 in green, and the third contact group 1526 in blue. Each contact group includes a lead electrode-tissue contact at a corresponding spinal cord segment targeting certain spinal nerve targets. (The last sentence appears to be incomplete and possibly refers to a different context.) Figure 15BIn the example shown, the first contact group 1522 is located in the T12-L1 segment and targets the dorsal column, dorsal root, DREZ, dorsolateral tract, and inhibitory interneurons. The second contact group 1524 is located in the L1-L2 segment and targets the midline dorsal root. The third contact group 1526 is located in the L1-L3 segment and targets the lateral dorsal root. In some examples, the spinal nerve targets of the contact group can be further identified based on the cephalic-caudic and / or intermediate-lateral location of the contact group relative to one or more spinal segments innervating the painful dermatome. Table 1 below shows examples of spinal nerve targets identified for different contact groups, depending on whether the electrode-tissue contact of the contact group is located in one or more spinal segments innervating the painful dermatome, or at the cephalic or caudal end of one or more spinal segments.
[0113] Table 1
[0114]
[0115]
[0116] Users can then program electrical stimulation therapy for individual targets in each contact group, such as by clicking the "Programming Individual Target" button 1528. Figure 15C-15E A programming screen is shown for programming the treatment of neural targets associated with the first, second, and third contact groups, respectively. Targets of interest can be displayed on the user interface, automatically identified by the neural target recognizer 1431 based on user input of lead placement and pain maps, as well as the associated painful dermatomes. Figure 15C The neural target 1531 identified for the first contact group is shown. Figure 15D The neural target 1541 identified for the second contact group is shown, and Figure 15E The neural target 1551 identified for the third contact group is shown. To program electrical stimulation therapy for the neural targets of the contact group, the user can select a stimulation mode from a drop-down menu 1532 based on sensory abnormalities or a drop-down list 1534 based on stimulation modes without sensory abnormalities, such as... Figure 15C The first contact assembly is shown in the diagram. The user can similarly obtain... Figure 15D The drop-down menu 1542 for stimulation modes based on sensory abnormalities or the drop-down menu 1544 for stimulation modes without sensory abnormalities is shown to select a stimulation mode for the neural target associated with the second contact group, or from, for example... Figure 15EThe drop-down menus 1552 (based on paresthesia) and 1554 (based on non-paresthesia) show the selection of a stimulation mode for the neural target associated with the third contact group. Drop-down menus 1532, 1534, 1542, 1544, 1552, and 1554 each include a list of candidate stimulation modes for the current contact group. Table 2 below shows examples of candidate paresthesia-based stimulation modes and candidate non-paresthesia stimulation modes for different contact groups. In this table and throughout the document, anodic (focal) stimulation is a mode designed to stimulate neural targets perpendicular to the lead. A turning mode refers to a turning algorithm. Rotation refers to a stimulation mode designed to better target fibers diagonally opposite the head-tail axis of the spinal cord. The FAST mode allows the delivery of stimulation pulses to provide deep, non-paresthesia pain relief over a short period (e.g., several minutes) by increasing circumferential inhibition. DHM is a stimulation mode that can target inhibitory interneurons on dorsal column fibers. LRAR mode refers to subsensory stimulation pulses delivered at a lower frequency than typical DHM. The stimulation mode circuit 1432 can generate a drop-down menu based on Table 2.
[0117] Table 2
[0118]
[0119]
[0120] A programming screen can be displayed based on the user's selection of a stimulus pattern based on sensory abnormalities. In some examples, such as... Figure 15C-15E As shown, separate programming screens can be displayed for user-selected stimulation patterns based on sensory abnormalities and user-selected stimulation patterns without sensory abnormalities, such as programming screens 1533, 1543, and 1553 for stimulation patterns based on sensory abnormalities, and programming screens 1535, 1545, and 1555 for stimulation patterns based on sensory abnormalities. The programming screens can prompt the user to provide and receive stimulation parameters (e.g., pulse width, amplitude, duty cycle, stimulation rate, modulation frequency, modulation depth, etc.) for the stimulation pattern at the identified neural target associated with the current contact group.
[0121] In some examples, users can select multiple candidate neural targets and program the corresponding neural stimulation therapy. Programmed therapy targeting a specific neural target (including stimulation patterns and parameters) is called a "program". Figure 15FA summary report 1560 displayed on a user interface is shown, which includes identified lateral spinal nerve targets organized as digitally labeled programs and corresponding electrical stimulation settings (e.g., stimulation patterns). In this example, five programs are shown. Programs 1 and 2 are associated with a first contact group, programs 3 and 4 with a second contact group, and program 5 with a third contact group. Test electrical stimulation energy can be delivered to the patient independently according to each of the five programs. The patient can provide feedback on pain relief in response to the electrical stimulation. “Optimal” neural targets with associated programs can be identified, such as those with the most significant pain relief effect. For example, if the patient instructs program 3 to produce the most significant pain relief effect, the user (e.g., a physician) can immediately know this from the summary report details of program 3 (in this case, delivering electrical stimulation at the second contact group using a burst mode to target the dorsal root). The electrical stimulator can be programmed to deliver clinical pain treatment (e.g., chronic pain stimulation) at the neural target using the corresponding stimulation setting according to program 3. In some examples, the programs (and associated neural targets) can be ordered in ascending or descending order of pain relief effect.
[0122] Figure 16A-16D The user interface for programming the optional lateral SCS for pain control is illustrated as an example. The "dermatome pattern" for SCS programming (as referenced above) is also shown. Figure 15A-15F Compared to the previous method, where user input based on pain maps and lead placement automatically identifies neural targets for each contact group, Figures 16A-16D A "manual mode" for SCS programming is illustrated, in which a user can manually select a neural target from a pool of selectable candidate spinal cord targets. The user can manually select the target based on factors such as the placement of at least one lead, available electrodes from impedance measurements, patient-specific anatomy, or instructions from a physician.
[0123] Figure 16A It shows something similar to Figure 15A The guide placement screen 1611 shows the guide placement. Pain diagrams and / or pain dermatomes may or may not be provided in manual mode. Once guide placement is complete, diagram 1612 showing guide placement on a spinal cord anatomy similar to that in drawing 1515 can be displayed on the user interface. Figure 15A The diagram also shows one or more contact groups, each of which includes a plurality of corresponding tissue contacts associated with electrodes on the same lead or two or more different leads, such as contact groups 1522, 1524 and 1526.
[0124] Users can select a group of contacts (e.g., a first group of contacts 1522) and use UI controls on the user interface, such as by clicking the “Programming Single Target” button 1616, to program electrical stimulation therapy for one or more targets associated with the selected group of contacts. Figure 16B-16D A programming screen is shown, in which a user can select a neural target from lists of optional candidate spinal cord targets associated with the first, second, and third contact groups, respectively. The optional candidate spinal cord targets, such as candidate target list 1621 for the first contact group, candidate target list 1631 for the second contact group, and candidate target list 1641 for the third contact group, can include candidate targets for the spinal cord segments where the contact groups are located. Figure 16B-16D In the examples shown, the same list of candidate targets is provided for different contact group groups, including dorsal column, dorsal horn, DREZ, dorsolateral fasciculus, branch root, and dorsal root. However, it is important to note that the candidate targets refer to one or more spinal cord segments within the corresponding contact group. For example, the "dorsal root" of the first contact group 1522 is the dorsal root of the T12-L1 segment, while the "dorsal root" of the second contact group 1524 is the dorsal root of the L1-L2 segment.
[0125] To program the electrical stimulation settings for a user-selected neural target (e.g., the "dorsal root" in the candidate target list 1621 of the first contact group) for a specific contact group, the user can select a stimulation mode from a pull-down menu 1622 based on sensory abnormalities or from a pull-down menu 1624 based on stimulation modes without sensory abnormalities, such as... Figure 16B The first contact assembly is shown in the diagram. The user can similarly access it from... Figure 16C The stimulation pattern for the neural target associated with the second contact group is determined by selecting from either the stimulation pattern drop-down menu 1632 based on sensory abnormality or the stimulation pattern drop-down menu 1634 without sensory abnormality, or by selecting from, for example... Figure 16D The stimulation pattern for the neural target associated with the third contact group is determined by selecting from either the abnormal stimulation pattern drop-down menu 1642 or the non-abnormal stimulation pattern drop-down menu 1644. Drop-down menus 1622, 1624, 1632, 1634, 1642, and 1644 each contain a list of available candidate stimulation patterns for the current contact group. Table 3 below shows examples of candidate abnormal stimulation patterns and candidate non-abnormal stimulation patterns for different contact groups, which can be used to generate the corresponding drop-down menus.
[0126] Table 3
[0127]
[0128] Similar to Figure 15C-15EThe programming screens shown can display separate programming screens for user-selected stimulation patterns based on sensory abnormalities (e.g., programming screens 1623, 1633, and 1643) and user-selected stimulation patterns without sensory abnormalities (e.g., programming screens 1625, 1635, and 1645). The programming screens can prompt the user to provide and receive stimulation parameters (e.g., pulse width, amplitude, duty cycle, stimulation rate, modulation frequency, modulation depth, etc.) for the stimulation pattern at the user-selected neural target associated with the current contact group. (See above reference...) Figure 15F The discussion may involve displaying identified lateral spinal nerve targets organized as a digitally labeled program and their corresponding electrical stimulation settings (e.g., stimulation patterns). The electrical stimulation energy can be delivered to the patient independently according to each program, and the “optimal” neural target with the relevant program can be identified based on the patient’s feedback regarding pain relief in response to the electrical stimulation. The user can program the electrical stimulator to deliver clinical pain treatment (e.g., chronic pain stimulation) according to the selected optimal program.
[0129] Figures 17A-17B The user interface for programming the SCS to target multiple Central Points of Stimulation (CPS) is shown, by way of example and not limitation, for using electrodes placed on different sections of leads near the lateral portion of the spinal cord. Figure 17A In this procedure, an epidural lead 1710 is placed in the T12-L2 segment to deliver electrical stimulation to help relieve knee pain. Monopolar anodic stimulation can be applied to the electrodes on the first lead segment 1712 to target the terminal portion, as the electrode-tissue contact in this region lies within the L3-L4 DREZ area (including the terminal portion from the branch root). Furthermore, bipolar stimulation can be applied to the electrodes on the second lead segment 1714 (located on the ventral side of the first lead segment 1712) to target the dorsal column, as the electrode-tissue contact in this region lies above the DREZ of the L3-L4 fibers. Figure 17B In this procedure, an epidural lead 1720 is placed in the T10-T12 segment to deliver electrical stimulation to help relieve pelvic pain. Monopolar anodic stimulation can be applied to the electrodes on the first lead segment 1722 to target the terminal portion, as the electrode-tissue contact in this region lies within the L1-L2 DREZ area (including the terminal portion from the branch root). Bipolar stimulation can be applied to the electrodes on the second lead segment 1724 (located cephalad to the first lead segment 1722) to target the dorsal column, as the electrode-tissue contact in this region lies above the DREZ of the L1-L2 fibers. Bipolar or tripolar stimulation can be applied to the electrodes on the third lead segment 1726 (located caudally to the first lead segment 1722) to target the dorsal root, as the electrode-tissue contact in this region lies below the DREZ of the L1-L2 fibers.
[0130] Figure 18 This is a flowchart of method 1800 for programming and applying an optional lateral SCS for pain control, shown by way of example and not limitation. Method 1800 can be performed using a medical system such as one of the neuromodulation systems 210 or 1400. Parts of method 1800 can be implemented in an external device, such as a device in external system 522, or one of the programming devices 213 or 413, CP 629, or RC 628. By performing method 1800, the programming device or external device can program the neuromodulation device (e.g., one of neuromodulation devices 212, 312, or 512, IPG 627, or electrical stimulator 1440) to deliver stimulation to various spinal nerve targets, such as one or more of spinal nerves, dorsal roots, dorsal root ganglia, etc.
[0131] At 1810, information regarding the placement of at least one lead near the lateral spinal cord segment can be received from the user via a user interface (such as user interface 1410). On the user interface, the user can select a lead type from several available lead types, including, for example, percutaneous cylindrical leads, linear paddles, multi-row paddles, or directional leads with segmented electrodes, and place the selected lead at a desired location on the graphical representation of the spinal cord displayed on the user interface. For example, the user can place the selected lead in the lateral portion of a specific spinal cord segment. Each selected lead includes an array of electrodes that docks with the graphical spinal cord representation at a corresponding electrode-tissue contact. In some examples, multiple leads can be selected and placed at corresponding locations on the graphical spinal cord representation.
[0132] At 1820, one or more lateral spinal nerve targets can be identified based on the lead placement information. Lateral spinal nerve targets can be identified automatically, such as using a nerve target recognizer 1431. Alternatively, lateral spinal nerve targets can be manually selected from a pre-generated list of candidate nerve targets displayed on the user interface, such as... Figure 16B-16D As shown. Electrode-tissue contacts can be grouped into one or more contact groups. A contact group includes multiple electrode-tissue contacts associated with electrodes on the same lead or two or more different leads. Spinal cord nerve targets at the corresponding spinal cord segment can be identified for each contact group. Figure 15B Examples of three automatically generated contact groups are shown, each group comprising electrode-tissue contacts targeting one or more spinal cord nerve targets. These contact groups can be displayed distinguishably on the user interface using different colors or presentations.
[0133] In some examples, the identification of one or more neural targets for a group of contact points can be further based on patient pain data, such as user input of one or more pain regions or one or more pain dermatomes, e.g. Figure 15A As shown. The cephalic-caudal and / or intermediate-lateral position of the contact group relative to one or more spinal segments innervating the painful dermatome can be determined based on lead placement information. As shown in Table 1, the spinal nerve target for the contact group can be identified depending on whether the electrode-tissue contact of the contact group is at the spinal segment of the painful dermatome or at the cephalic or caudal end of the spinal segment of the painful dermatome.
[0134] At point 1830, the user can select from multiple optional stimulation patterns for stimulating the lateral spinal nerve target for identification. Optional electrical stimulation patterns can include stimulation patterns based on sensory abnormalities and stimulation patterns without sensory abnormalities. Sensory abnormality-based stimulation can induce sensory abnormalities during stimulation. Examples of sensory abnormality-based stimulation patterns include monopolar stimulation, bipolar stimulation, tripolar stimulation, turning, sensory, and rotational stimulation. The stimulation can be cathodic or anodic. Stimulation patterns without sensory abnormalities typically do not induce sensory abnormalities during stimulation. Examples of stimulation patterns without sensory abnormalities include FAST, DHM, burst, and LRAR modes. In one example, multiple recommended sensory abnormality-based stimulation patterns and multiple candidate stimulation patterns without sensory abnormalities can be generated for each contact group. The user can select a sensory abnormality-based stimulation pattern and / or a stimulation pattern without sensory abnormalities for a given contact group. The user can then program one or more stimulation parameters, such as current or voltage amplitude, pulse width, pulse shape (waveform), pulse rate, or duty cycle, and other parameters.
[0135] In some examples, multiple central stimulation points (CPSs) can be generated based on the lead placement, such as via stimulation pattern circuit 1432. Each CPS represents the focal point of a stimulation field established by stimulation energy from multiple electrodes applied to a portion of the epidural lead. The stimulation fields corresponding to multiple CPSs can activate corresponding spinal nerve targets at different spinal cord segments. To generate multiple CPSs, the user can program the corresponding multiple electrodes on the lead with appropriate stimulation patterns and parameters based on sensory abnormalities or the absence of sensory abnormalities, as described above. Figures 17A-17B The subject of discussion.
[0136] At 1840, clinical electrical stimulation energy can be applied to the selected neural target according to the corresponding stimulation pattern. In some examples, at 1820, two or more lateral spinal nerve targets can be automatically identified or manually selected. Electrical stimulation energy can be delivered to stimulate each of the two or more identified lateral spinal nerve targets individually and independently, based on stimulation patterns and stimulation parameters determined or selected for each of the two or more identified lateral spinal nerve targets. The patient can provide feedback on pain relief in response to electrical stimulation at the two or more identified candidate neural targets. Based on the patient feedback, a “best” neural target, such as the one with the most significant pain relief, can be selected from the two or more identified candidate neural targets. Clinical pain treatment (e.g., chronic pain stimulation) can then be delivered at the selected “best” neural target according to the corresponding stimulation settings. The identified candidate neural targets and the best neural target, along with the corresponding stimulation patterns and stimulation parameters, can be stored in a storage device, such as storage device 419 of programming device 413.
[0137] Figure 19 A block diagram of the example machine 1900 is shown in general, on which any one or more of the techniques (e.g., methods) discussed herein can be executed. Parts of this description may be applicable to the computational framework of various parts of a neural modulation device or an externally programmed device.
[0138] In alternative embodiments, machine 1900 may operate as a standalone device or may be connected (e.g., networked) to other machines. In a networked deployment, machine 1900 may operate as a server machine, a client machine, or both in a server-client network environment. In one example, machine 1900 may act as a peer machine in a peer-to-peer (P2P) (or other distributed) network environment. Machine 1900 may be a personal computer (PC), tablet PC, set-top box (STB), personal digital assistant (PDA), mobile phone, network device, network router, switch, or bridge, or any machine capable of executing instructions (sequential or otherwise) specifying the actions to be taken by that machine. Furthermore, although only a single machine is shown, the term "machine" should also be considered to include any collection of machines, such as cloud computing, Software as a Service (SaaS), and other computer cluster configurations, that individually or jointly execute a set (or more) of instructions to perform any one or more methods discussed herein.
[0139] As described herein, examples may include logic or multiple components or mechanisms, or those operable by them. A circuit set is a collection of circuits implemented in a tangible entity including hardware (e.g., simple circuits, gates, logic, etc.). Circuit set membership may vary over time and with the variability of the underlying hardware. A circuit set includes members that can perform a specified operation individually or in combination during operation. In one example, the hardware of a circuit set may be invariably designed to perform a specific operation (e.g., hardwired). In one example, the hardware of a circuit set may include physically connected components (e.g., execution units, transistors, simple circuits, etc.) that include physically modified computer-readable media (e.g., magnetic, electrical, movable placement of invariant aggregated particles, etc.) to encode instructions for a specific operation. When the physical components are connected, the fundamental electrical characteristics of the hardware components are altered, e.g., from insulator to conductor, and vice versa. Instructions enable embedded hardware (e.g., execution units or loading mechanisms) to create members of the circuit set in the hardware via variable connections to perform portions of a specific operation during operation. Thus, when the device is operating, computer-readable media are communicatively coupled to other components of the circuit set members. In one example, any physical component can be used in more than one member of more than one circuit set. For example, under operation, an execution unit can be used in a first circuit of a first circuit set at one point in time, and reused at different times by a second circuit of the first circuit set or a third circuit of the second circuit set.
[0140] Machine (e.g., computer system) 1900 may include a hardware processor 1902 (e.g., a central processing unit (CPU), a graphics processing unit (GPU), a hardware processor core, or any combination thereof), main memory 1904, and static memory 1906, some or all of which may communicate with each other via an interconnect (e.g., a bus) 1908. Machine 1900 may also include a display unit 1910 (e.g., a raster display, a vector display, a holographic display, etc.), an alphanumeric input device 1912 (e.g., a keyboard), and a user interface (UI) navigation device 1914 (e.g., a mouse). In one example, display unit 1910, input device 1912, and UI navigation device 1914 may be a touchscreen display. Machine 1900 may additionally include a storage device (e.g., a drive unit) 1916, a signal generation device 1918 (e.g., a speaker), a network interface device 1920, and one or more sensors 1921, such as a global positioning system (GPS) sensor, a compass, an accelerometer, or other sensors. Machine 1900 may include output controller 1928, such as serial (e.g., Universal Serial Bus (USB), parallel or other wired or wireless (e.g., infrared (IR), near field communication (NFC) etc.) connections, to communicate or control one or more peripheral devices (e.g., printers, card readers, etc.).
[0141] Storage device 1916 may include machine-readable medium 1922 on which one or more sets of data structures or instructions 1924 (e.g., software) are stored, which embody or are utilized by any one or more of the technologies or functions described herein. During execution of instructions 1924 by machine 1900, instructions 1924 may also reside wholly or at least partially in main memory 1904, static memory 1906, or hardware processor 1902. In one example, one or any combination of hardware processor 1902, main memory 1904, static memory 1906, or storage device 1916 may constitute a machine-readable medium.
[0142] Although machine-readable medium 1922 is shown as a single medium, the term "machine-readable medium" can include a single medium or multiple media (e.g., a centralized or distributed database, and / or associated caches and servers) configured to store one or more instructions 1924.
[0143] The term "machine-readable medium" can include any medium capable of storing, encoding, or carrying instructions executable by machine 1900 and enabling machine 1900 to perform any one or more of the techniques disclosed herein, or any medium capable of storing, encoding, or carrying data structures used or associated with such instructions. Non-limiting examples of machine-readable media can include solid-state memory as well as optical and magnetic media. In one example, a large-scale machine-readable medium includes a machine-readable medium containing multiple particles with invariant (e.g., rest) mass. Therefore, a large-scale machine-readable medium is not a transient propagating signal. Specific examples of large-scale machine-readable media can include: non-volatile memory, such as semiconductor memory devices (e.g., electrically programmable read-only memory (EPROM), electrically erasable programmable read-only memory (EPSOM)) and flash memory devices; disks, such as internal hard disks and removable disks; magneto-optical disks; and CD-ROM and DVD-ROM disks.
[0144] Instructions 1924 can be further sent or received via a communication network 1926 using a transmission medium, via a network interface device 1920 that utilizes any of a variety of transport protocols (e.g., Frame Relay, Internet Protocol (IP), Transmission Control Protocol (TCP), User Datagram Protocol (UDP), Hypertext Transfer Protocol (HTTP), etc.). Example communication networks may include local area networks (LANs), wide area networks (WANs), packet data networks (e.g., the Internet), mobile phone networks (e.g., cellular networks), conventional telephone (POTS) networks, and wireless data networks (e.g., those referred to as…). The Institute of Electrical and Electronics Engineers (IEEE) 802.11 family of standards is known as The network interface device 1920 may include one or more physical jacks (e.g., Ethernet, coaxial, or telephone jacks) or one or more antennas to connect to the communication network 1926. In one example, the network interface device 1920 may include multiple antennas to perform wireless communication using at least one of single-input multiple-output (SIMO), multiple-input multiple-output (MIMO), or multiple-input single-output (MISO) technologies. The term "transmission medium" should be considered to include any intangible medium capable of storing, encoding, or carrying instructions for execution by the machine 1900, and includes digital or analog communication signals or other intangible media to facilitate communication of such software.
[0145] Various implementations are illustrated in the figure above. One or more features from one or more of these embodiments can be combined to form other embodiments.
[0146] The methods described herein may be implemented, at least in part, by a machine or computer. Some examples may include a computer-readable or machine-readable medium encoded with instructions operable to configure an electronic device or system to perform the methods described in the examples above. Implementations of this method may include code, such as microcode, assembly language code, higher-level language code, etc. This code may include computer-readable instructions for performing various methods. This code may form part of a computer program product. Furthermore, the code may be tangibly stored on one or more volatile or non-volatile computer-readable media during execution or at other times.
[0147] The above detailed description is intended to be illustrative and not restrictive. Therefore, the scope of this disclosure should be determined by reference to the appended claims and the full scope of their equivalents.
Claims
1. A system for providing spinal cord electrical stimulation for pain control in a patient, the system comprising: The programming device is configured as follows: Receive information regarding the placement of at least one lead in the vicinity of the lateral portion of the spinal cord; One or more lateral spinal nerve targets are identified based on information regarding the placement of the at least one lead; as well as Receive user selection from an optional stimulation pattern for stimulating one or more identified lateral spinal nerve targets; as well as An electrical stimulator, configured to apply electrical stimulation energy via at least one lead to one or more identified lateral spinal cord targets based on a user selection from the selectable stimulation modes. Wherein, the one or more lateral spinal cord targets include at least one of the following: A first lateral spinal cord target identified for a first contact group comprising multiple electrode-tissue contacts associated with electrodes on the same lead or two or more different leads, including the dorsal column, dorsal root, dorsal root entry area, dorsolateral tract, and inhibitory interneuron. A second lateral spinal nerve target identified for a second group of contacts, including one or more midline dorsal roots, comprising multiple electrode-tissue contacts associated with electrodes on the same lead or two or more different leads; or A third lateral spinal nerve target, including one or more lateral dorsal roots, is identified for a third contact group comprising multiple electrode-tissue contacts associated with electrodes on the same lead or two or more different leads.
2. The system according to claim 1, wherein, The one or more lateral spinal cord targets include at least one of the dorsal root entry area, dorsolateral tract, dorsal root, or dorsal branch root.
3. The system according to any one of claims 1-2, wherein, The optional stimulation modes include at least one of the following: Monopolar stimulation mode; Bipolar stimulation mode; Tripolar stimulation mode; Steering mode; Sensory patterns; Rotation mode; A rapid-acting subsensory therapy modality; Back angle modulation mode; Burst mode; or Low-rate active recharge mode.
4. The system according to any one of claims 1-2, wherein, The placement of at least one lead includes a user selection from two or more of cylindrical leads, paddle leads, directional leads, or curved leads, wherein the curved leads include two or more cascaded lead segments arranged at an angle to each other.
5. The system according to any one of claims 1-2, wherein, The programming device is configured to identify the one or more lateral spinal cord targets, including: Generate one or more contact sets, each contact set including a lead electrode-tissue contact on a lateral portion of the patient's spinal cord; and For each of the one or more contact groups, one or more lateral spinal nerve targets are identified.
6. The system according to claim 5, wherein, The programming device is configured to: Receive information about painful areas on the patient's body, the painful areas corresponding to one or more dermatomes; and Further, based on the cephalic-caudal or intermediate-lateral position of the contact group relative to the spinal cord segment innervating the one or more dermatomes corresponding to the pain area, one or more lateral spinal cord targets of the contact group are identified.
7. The system according to claim 5, wherein, For each of the one or more contact groups, the selectable stimulation pattern includes one or more candidate stimulation patterns based on sensory abnormalities and one or more candidate stimulation patterns without sensory abnormalities.
8. The system according to claim 5, wherein, The programming device is configured to: For each of the one or more contact groups, a user selection is received from candidate spinal nerve targets; and It provides optional stimulation modes for candidate spinal cord targets selected by the user.
9. The system according to claim 8, wherein, The candidate spinal cord targets include one or more of the following: Back post; Back angle; dorsolateral band; Back root marrow entry area; dorsal basal root; or Back root.
10. The system according to any one of claims 8-9, wherein, For each of the candidate spinal cord targets, the optional stimulation patterns include one or more candidate stimulation patterns based on sensory abnormalities and one or more candidate stimulation patterns without sensory abnormalities.
11. The system according to any one of claims 1-2, wherein: The electrical stimulator is configured to apply test electrical stimulation energy individually and independently to the two or more identified lateral spinal cord targets, based on corresponding stimulation patterns selected for each of the two or more identified lateral spinal cord targets. as well as The programming device is configured to select one of the two or more identified lateral spinal nerve targets based on patient feedback of pain relief in response to electrical stimulation applied individually and independently to the two or more identified lateral spinal nerve targets. The electrical stimulator is configured to apply clinical electrical stimulation energy to the selected neural target according to the corresponding stimulation mode.
12. The system of claim 11, further comprising a display configured to display the two or more identified lateral spinal nerve targets and stimulation patterns selected for each of the two or more identified lateral spinal nerve targets. in, The programming device is configured to receive user selection of one of the two or more identified lateral spinal nerve targets based on patient feedback of pain relief in response to electrical stimulation applied individually and independently to each of the identified lateral spinal nerve targets.
13. The system according to any one of claims 1-2, wherein, The programming device is configured to receive user selections from the optional stimulation patterns, which include two or more stimulation patterns to be applied to corresponding two or more electrode sets to stimulate corresponding two or more lateral spinal nerve targets.
14. The system according to claim 13, wherein, The user selection of the two or more stimulation modes includes a monopolar anodic stimulation mode applied to a first electrode set to stimulate the dorsal root entry area at the spinal cord segment, and a bipolar stimulation mode applied to a second electrode set to stimulate the dorsal column or dorsal root at the spinal cord segment.
Citation Information
Patent Citations
System to incorporate lead information from image
CN105682734A
Systems and methods for placement of spinal cord stimulator leads
CN109937003A
